Premium
Photosensitivity and cancer immune‐targeted therapies
Author(s) -
Lembo Serena,
Raimondo Annunziata,
Conti Valeria,
Venturini Marina
Publication year - 2020
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/phpp.12533
Subject(s) - medicine , discontinuation , phototoxicity , adverse effect , cancer , chemotherapy , quality of life (healthcare) , intensive care medicine , dermatology , photosensitivity , oncology , immunotherapy , malignancy , biochemistry , chemistry , physics , nursing , quantum mechanics , in vitro
The novel group of immunological agents used for solid tumors has importantly improved the quality of life and the survival rate of oncologic patients. Compared to conventional chemotherapy agents, they are more effective and less toxic. However, adverse cutaneous effects are commonly observed, and in some cases, they may induce treatment discontinuation, with heavy impact on patient prognosis. Among these, photosensitive reactions, either phototoxic or photoallergic, are increasing. Much remains to be clarified on the understanding of their prevention, diagnosis, and management. We have reviewed the literature about photosensitive reactions occurring during oncologic immunotherapies. Early dermatological diagnosis and adequate management, with oncologist's cooperation, is fundamental.